Cancer Network: Mesa Discusses Importance of Pacritinib Accelerated Approval for Myelofibrosis With Severe Thrombocytopenia
March 1, 2022
Dr. Ruben Mesa, executive director of the Mays Cancer Center, gives video comments about FDA approval of a new drug for a chronic leukemia. Watch Video